FOOD SCIENCE ›› 2020, Vol. 41 ›› Issue (3): 127-137.doi: 10.7506/spkx1002-6630-20181016-164

• Nutrition & Hygiene • Previous Articles     Next Articles

Effect of Phytosterol Esters on Selected Serum Metabolites of Rats with Non-alcoholic Fatty Liver Disease (NAFLD)

OUYANG Pengling, GUAN Qi, QU Dan, DING Xinwen, YANG Li, SONG Lihua   

  1. (1. College of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China; 2. Department of Nutrition, Shanghai the Seventh People’s Hospital, Shanghai 200137, China; 3. Bor S. Luh Food Safety Research Center, Shanghai Jiao Tong University, Shanghai 200240, China)
  • Online:2020-02-15 Published:2020-02-26

Abstract: Based on our previous studies, the effect of phytosterol esters (PSE) on selected serum small-molecule metabolites of rats with non-alcoholic fatty liver disease (NAFLD) was investigated in the present study. Further, we explored the molecular mechanism underlying the preventive effect of PSE on NAFLD. Rats were fed with a high-fat diet to establish a NAFLD animal model, and PSE fortified milk at low (0.05 g/100 g mb·d) and high (0.10 g/100 g mb·d) doses were respectively given to rats in the PSE intervention groups by intragastric administration at the same time. Serum small-molecule metabolites of NAFLD rats were detected using ultra performance liquid chromatography-quadrupole-tandem time-of-flight mass spectrometry (UPLC-Q-TOF-MS). In addition, Progenesis QI v2.3 software, UNIFI data analysis platform and Metabo Analyst were used to analyze differential serum metabolites and the metabolic pathways involving the identified differential metabolites. Our results showed that 27 metabolites were identified, including diglyceride (14:0/22:2(13Z,16Z)/0:0, 15:0/18:3 (6Z,9Z,12Z)/0:0, 16:0/20:3(8Z,11Z,14Z)/0:0, 18:1(11Z)/18:1(11Z)/0:0), glucosylceramide (d18:2/20:0), lactosylceramide (d18:1/18:1(9Z)), heneicosanedioic acid, lysophospholipid (Lyso PC) (15:0, 16:1(9Z), 20:3(5Z,8Z,11Z), 20:3(8Z,11Z,14Z), 18:1(9Z), 18:2(9Z,12Z)), phosphatidic acid(22:4(7Z,10Z,13Z,16Z)/0:0), phosphatidylcholine(16:0/20:3(5Z,8Z,11Z), 16:0/P-18:0, 18:1(11Z)/20:1(11Z), 17:1(10Z)/0:0, 20:3(8Z,11Z,14Z)/18:0, O-18:0/0:0), phosphatidylethanolamine (16:0/0:0, 18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z), 20:3(8Z,11Z,14Z)/0:0, 18:4(6Z,9Z,12Z,15Z)/18:0), phosphatidylinositol(20:0/22:2 (13Z,16Z)) and sphingomyelin (d16:1/25:0, d18:1/24:0). The preventive effect of PSE was exerted on NAFLD probably through correcting high-fat diet-induced disturbance of the glycerophospholipid and lipid metabolism pathways.

Key words: phytosterol esters, non-alcoholic fatty liver disease, serum small-molecule metabolites, ultra performance liquid chromatography-quadrupole-tandem with time-of-fight mass spectrometry

CLC Number: